SCHEMBL694532

SCHEMBL694532

Cc1[c]ccc2[nH]nc(-c3ccc(F)cc3)c12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP2K4 P45985 7/20 0.42
MAPK1 P28482 4/20 0.42
MAPK6 Q16659 2/20 0.42
MAPKAPK2 P49137 1/20 0.42
NTRK1 P04629 2/20 0.39
DAPK3 O43293 1/20 0.39
PRKD3 O94806 1/20 0.39
MAP4K4 O95819 1/20 0.39
PAK4 O96013 1/20 0.39
ABL1 P00519 1/20 0.39
LCK P06239 1/20 0.39
CSF1R P07333 1/20 0.39
RET P07949 1/20 0.39
IGF1R P08069 1/20 0.39
MET P08581 1/20 0.39
PDGFRB P09619 1/20 0.39
FGFR1 P11362 1/20 0.39
PRKACA P17612 1/20 0.39
FLT1 P17948 1/20 0.39
LTK P29376 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL694856 0.84 ALDH1A1 (0.47) MAP2K4MAPK1MAPK6MAPKAPK2PRKD3
SCHEMBL695846 0.83 MAP2K4 (0.41) MAP2K4MAPK1MAPK6MAPKAPK2NTRK1
SCHEMBL5868327 0.70 PDPK1 (0.44) NTRK1DAPK3PRKD3MAP4K4PAK4
SCHEMBL695357 0.70 MAP2K4 (0.45) MAP2K4MAPK1MAPK6MAPKAPK2NTRK1
SCHEMBL5078605 0.69 MAP2K4 (0.55) MAP2K4MAPK1MAPK6MAPKAPK2NTRK1
SCHEMBL5072725 0.69 KDR (0.59) MAP2K4MAPK1MAPK6MAPKAPK2NTRK1
SCHEMBL441029 0.69 KDR (0.51) MAP2K4MAPK1MAPK6MAPKAPK2NTRK1
SCHEMBL443588 0.69 PDPK1 (0.51) MAP2K4MAPK1MAPK6MAPKAPK2NTRK1
SCHEMBL5775137 0.68 MAP2K4 (0.50) MAP2K4MAPK1MAPK6MAPKAPK2FGFR1
SCHEMBL3770383 0.68 PDE3B (0.46) MAP2K4MAPK1MAPK6MAPKAPK2NTRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421825-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS Janssen Pharmaceutica N.V. (BE) 2012-02-29 EP claimed
WO-2010124108-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2010-10-28 WO claimed
EP-3197450-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF FIBROSIS INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2017-08-02 EP disclosed
WO-2016046130-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF FIBROSIS INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2016-03-31 WO disclosed
EP-2421825-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS Janssen Pharmaceutica N.V. (BE) 2012-02-29 EP disclosed
WO-2010124108-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2010-10-28 WO disclosed